Evaluating a semantic recognition task in Alzheimer Disease
Official title: A Sensitive Measurement Proposal in Alzheimer's Disease: Semantic Recognition Task
Run by Istanbul University · NCT05711888 · Data updated 2026-11-12
This study tests a special memory task for people with Alzheimer’s to see how it relates to brain activity and could help improve diagnosis and treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Istanbul University Academic / other |
| Locations | 1 site (Beşiktaş, Istanbul) |
| Status | Recruiting |
| Started | December 21, 2022 |
| Main results expected | September 20, 2025 |
| Study ends | December 26, 2027 |
| Registry record updated | October 2, 2024 |
| Trial ID | NCT05711888 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Alzheimer Disease who have undergone biomarker analysis.
✕Probably not a fit
Patients who are illiterate may not benefit from this study due to the nature of the semantic recognition tasks involved.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to observe the outcomes of a semantic recognition task specifically designed for patients with Alzheimer Disease. It focuses on understanding how this task relates to temporal lobe activity, which is crucial for memory function. By utilizing a recognition procedure that goes beyond traditional memory testing, the study seeks to provide insights that could enhance clinical practice in diagnosing and managing Alzheimer Disease. Participants will undergo biomarker analysis to confirm their Alzheimer's status.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and interventions for patients with Alzheimer Disease.
How similar studies have gone: While this approach is innovative, similar studies have not been extensively documented, indicating a novel exploration in the field.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * to have biomarker analysis for Alzheimer disease (positive or negative). Exclusion Criteria: * illiteracy
Where it's running
-
Jbid Dursun Uncu
Beşiktaş, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Jbid Dursun Uncu, Psy. M.
- Email: jbiddursun@gmail.com
- Phone: +905339390273
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Tau changes after hip or knee replacement surgery
Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.
-
Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Mild Alzheimer's Dementia
This study will test whether a low-dose brain radiation treatment using HeLaXON helps people with mild Alzheimer's dementia improve or stabilize thinking and daily function.
-
Cervical lymphatic surgery to see if it helps people with mild Alzheimer’s
We’re testing a surgical approach in people with mild Alzheimer’s to see if creating alternative neck lymph drainage routes can affect brain biomarkers and daily function.
-
Transcranial random noise stimulation for behavioral and psychological symptoms in Alzheimer's disease
This trial tests whether high-frequency transcranial random noise stimulation can help people with early Alzheimer's disease who have BPSD, compared to a sham treatment.
-
Testing LY4405094 in healthy people and people with Alzheimer’s disease
This study tests LY4405094 to see if it is safe and how it behaves in the body, including how it reaches the brain fluid in healthy participants and how it affects a brain protein in people with Alzheimer's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.